P. Rao
Pharmacology · with Knaus · 2008
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 13 citations into it
Whom P. Rao trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from P. Rao's perspective
Ordered by how strongly the researchers P. Rao trusts endorse each paper. Same corpus, a different order for every researcher.
- Cyclooxygenases: structural, cellular, and molecular biology. (Annual Review of Biochemistry)
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases (Nature reviews. Drug discovery)
- Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. (Circulation)
- The coxibs, selective inhibitors of cyclooxygenase-2. (New England Journal of Medicine)
- 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. (Journal of Medicinal Chemistry)
- Risk of cardiovascular events associated with selective COX-2 inhibitors. (Journal of the American Medical Association (JAMA))
- COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression (Proceedings of the National Academy of Sciences of the United States of America)
- Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. (New England Journal of Medicine)
- Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration (Proceedings of the National Academy of Sciences of the United States of America)
- The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* (Journal of Biological Chemistry)